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Background

Results (cont’d)

Results

• Antibiotic resistance is one of the most serious and
growing threats to public health
• Infectious disease (ID) pharmacists monitor usage and
resistance patterns to facilitate appropriate antibiotic
use

Reports Run for Antimicrobial Stewardship
Average number of reports

• Current state:
• A third-party clinical surveillance program identifies
patients for antimicrobial surveillance (AMS)
• Requires constant shifting between platforms to do
a comprehensive review
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Figure 1. Reports run for antimicrobial stewardship. After implementation,
both the average number of reports run per day and the average number
of reports run per pharmacist per day decreased.

Document agents appropriate to continue

Mark date for next review, as appropriate

a)

Objective

Figure 3. Standardized restricted anti-infective review workflow. Prioritization is
primarily driven by Restricted Anti-Infective column. For patients within the same
priority group, ID pharmacist can consider using the ID consult column and
additional information in the patient overview report to facilitate prioritization.

• Optimize tools to perform antimicrobial- and culturebased surveillance and to report antimicrobial
consumption within an EHR to improve the efficiency
of AMS services

Discussion

• Workgroup discussions provided an opportunity to
identify differences in workflows among sites

a

Methods

b)

Limitations:
• Implementation of AMS-focused EHR module delayed
due to COVID-19

• Conducted a one-week time study using current
workflows
• Established a baseline of the number of patients
reviewed using the third-party clinical surveillance
program

Future Directions:
• Development of a blood culture-based patient list
workflow
• Develop reporting tools to participate in NHSN
reporting
• Standardization of all AMS-focused services with
quantitative metrics

• Consulted stakeholders:
• Discussed current AMS workflows across the system
• Aligned plans with system-wide initiatives
• Developed deliverables:
• Patient list-based workflow within the EHR
• Custom columns to help identify and prioritize the
most acute or complex patients
• Patient overview report to highlight the most
pertinent information

Conclusions
Figure 2. Restricted anti-infective patient list and report. (a) “Restricted
Abx” column displays a numerical icon for new anti-infective regimens, a
clock when follow-up is needed, or a green check when review is
completed. (b) Form to document agents appropriate to continue, followed
by a patient overview form to facilitate comprehensive patient review.

• Patient list-based workflow introduced standardization
that was well-received by stakeholders

